Publications
- Expression of human BRCA1 Delta 17-19 alternative splicing variant with a truncated BRCT domain in MCF-7 cells results in impaired assembly of DNA repair complexes and aberrant DNA damage response2013 | First Faculty of Medicine, Third Faculty of Medicine
- The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer2013 | First Faculty of Medicine
- The BRCA1 alternative splicing variant Delta 14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells2012 | First Faculty of Medicine, Third Faculty of Medicine
- Contribution of the Beta-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity2012 | First Faculty of Medicine
- Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma2011 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Population-based study of BRCA1/2 mutations: family history based criteria identify minority of mutation carriers.2010 | First Faculty of Medicine
- CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer.2010 | First Faculty of Medicine
- Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene2010 | First Faculty of Medicine
- Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients.2010 | First Faculty of Medicine
- The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population2009 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
Loading network view...